Accessibility Menu
Bio Essence logo

Bio Essence

(OTC) BIOE

Current Price$0.27
Market Cap$12.65M
Since IPO (2022)-46%
5 YearN/A
1 Year+146%
1 Month-1%

Bio Essence Financials at a Glance

Market Cap

$12.65M

Revenue (TTM)

$2.38M

Net Income (TTM)

$1.31M

EPS (TTM)

$0.03

P/E Ratio

8.04

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.27

Volume

1,000

Open

$0.27

Previous Close

$0.27

Daily Range

$0.27 - $0.27

52-Week Range

$0.05 - $0.52

Estimated Earnings Date

N/A

BIOE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bio Essence

Industry

Pharmaceuticals

Employees

4

CEO

Yin Yan, MBA

Headquarters

Irvine, CA 92618, US

BIOE Financials

Key Financial Metrics (TTM)

Gross Margin

72.70%

Operating Margin

55.60%

Net Income Margin

55.02%

Return on Equity

-53.81%

Return on Capital

N/A

Return on Assets

165.69%

Earnings Yield

12.44%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.65M

Shares Outstanding

46.81M

Volume

1.00K

Avg. Volume

1.85K

Financials (TTM)

Gross Profit

$1.73M

Operating Income

$1.32M

EBITDA

$1.32M

Operating Cash Flow

$1.18M

Capital Expenditure

$0.00

Free Cash Flow

$1.18M

Cash & ST Invst.

$36.18K

Total Debt

$1.57M

Bio Essence Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$500.54K

+2155.8%

Gross Profit

$319.35K

+1451.2%

Gross Margin

63.80%

N/A

Market Cap

$12.65M

N/A

Market Cap/Employee

$6.33M

N/A

Employees

2

N/A

Net Income

$205.37K

+199.8%

EBITDA

$215.80K

+205.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$36.18K

N/A

Total Debt

$1.57M

-42.9%

Accounts Receivable

$380.49K

+85.2%

Inventory

$0.00

N/A

Long Term Debt

$55.68K

-81.6%

Short Term Debt

$1.51M

-38.1%

Return on Assets

1.66%

N/A

Return on Invested Capital

-96.29%

N/A

Free Cash Flow

-$411.97K

-1480.3%

Operating Cash Flow

-$411.97K

-1480.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RVVTFRevive Therapeutics Ltd.
$0.02+17.65%
RAFARafarma Pharmaceuticals, Inc.
$0.02+0.00%
LVVVLiveWire Ergogenics, Inc.
$0.00+0.00%
UBQUUbiquitech Software Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.92-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.30-0.15%
CLROClearOne
$6.48+1.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$73.35-0.05%

Questions About BIOE

What is the current price of Bio Essence?

Bio Essence is trading at $0.27 per share.

What is the 52-week range for Bio Essence?

Over the past 52 weeks, Bio Essence has traded between $0.05 and $0.52.

How much debt does Bio Essence have?

As of the most recent reporting period, Bio Essence reported total debt of $1.57M.

How much cash does Bio Essence have on hand?

Bio Essence reported $36.18K in cash and cash equivalents in its most recent financial results.

What is Bio Essence’s dividend yield?

Bio Essence does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.